Reporting Manager
Madison Avenue International LP
Symbol
SAGE
Shares outstanding
61,509,538 shares
Disclosed Ownership
4,920,763 shares
Ownership
8%
Form type
SCHEDULE 13G
Filing time
01 Apr 2025, 17:35:13 UTC
Date of event
25 Mar 2025
Next filing
14 Aug 2025

Sponsored

Quoteable Key Fact

"Madison Avenue Partners, LP disclosed 8% ownership in Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) on 25 Mar 2025."

Quick Takeaways

  • Madison Avenue Partners, LP filed SCHEDULE 13G for Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE).
  • Disclosed ownership: 8%.
  • Date of event: 25 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 01 Apr 2025, 17:35.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue International LP 8% 4,920,763 0 4,920,763 /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Madison Avenue Partners, LP 8% 4,920,763 0 4,920,763 /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
EMAI Management, LLC 8% 4,920,763 0 4,920,763 /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 8% 4,920,763 0 4,920,763 /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 8% 4,920,763 0 4,920,763 /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 8% 4,920,763 0 4,920,763 /s/ Eli Samaha Eli Samaha